Trials / Completed
CompletedNCT01106911
Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment
Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment: a Prospective Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,080 (actual)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- Female
- Age
- 35 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to demonstrate that digital breast tomosynthesis (DBT) in combination with full field digital mammography (FFDM) has the potential to reduce significantly baseline screening recall rates without a loss in the detection of cancers. The primary hypothesis of the study is that DBT in combination with FFDM will reduce baseline screening mammography recall rates in negative examinations by at least 20%.
Detailed description
The FFDM images and the FFDM images with the DBT images will be interpreted independently by two experienced radiologists under standard clinical screening procedures. Recommended recall rates will be assessed and compared as a result of each of the two interpretations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | tomosynthesis and screening mammography | All eligible subjects will undergo both full field digital mammography and digital breast tomosynthesis. |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2014-09-01
- First posted
- 2010-04-20
- Last updated
- 2016-03-25
- Results posted
- 2016-03-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01106911. Inclusion in this directory is not an endorsement.